Alternate Day Dosing of Pomalidomide in Patients With Refractory Multiple Myeloma

Clinical trial NCT03520985 · TERMINATED

Trial details

NCT number: NCT03520985
Sponsor: Swiss Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Refractory Multiple Myeloma

Start date: 2018-10-01
Primary completion: 2021-02-03
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.